Morning Bid: Corporate scatter | Reuters
A look at the day ahead in U.S. and global markets from Mike Dolan.A hail of mega corporate updates distracted...
archiveANLINS
Why Europe’s drug shortages may get worse
Most European countries reporting shortages of antibioticsLow generic drug prices mean razor-thin margins for firmsCompanies say they cannot boost output...
China energy rethink can keep Europe warm
HONG KONG, Feb 7 (Reuters Breakingviews) - Beijing's energy policy will indirectly support Europe. A post-Covid economic rebound will increase...
Analysis: Hawkish Fed could hobble volatility funds’ stock buying spree
NEW YORK, Feb 1 (Reuters) - Volatility-linked funds estimated to be buying as much as $2 billion in U.S. equities...
U.S. readies $2 billion-plus Ukraine aid package with longer-range weapons, officials say
WASHINGTON, Jan 31 (Reuters) - The United States is readying more than $2 billion worth of military aid for Ukraine...
Euro-banks have done their time in valuation jail
LONDON, Jan 26 (Reuters Breakingviews) - European banks undeniably earned their reputations as financial ne’er-do-wells. Their low stock-market valuations were...
After a long, cold year, investors are flocking back to Europe
Equity investors overweight Europe at 11-month highEuro STOXX has beaten S&P by over 18 pct points since SeptEuro on best...
Morning Bid: Japan hesitates | Reuters
A look at the day ahead in U.S. and global markets from Mike Dolan.Judging by Wednesday's reaction, world markets reckon...
Column: Funds jump back into copper, betting on Chinese recovery
LONDON, Jan 17 (Reuters) - Copper has begun the New Year on a surge, with funds piling back into the...
Morning Bid: Money in the bank
A look at the day ahead in U.S. and global markets from Mike Dolan.Flush with relief that U.S. inflation is...
